Most p53 mutations are located within the DBD (96–293 aa) at several hotspots, such as R175, R248, R273, and R282, leading further to “gain of function” (GOF), which plays a significant role in promoting cancer progression and chemoresistance (45–48). This evidence concerns the gene TP53 and cancer.